CClinicalTrials.gg
CompletedNCT05485311FRSTPGaM-EWUpdated Aug 3, 2022

The Influence of the Results of Surgical Treatment in Patients With Gunshot and Mine-explosive Wounds on the Formation of Chronic Pain

An observational study in Chronic Pain, sponsored by Bogomolets National Medical University. Completed at 1 site in Ukraine. Open to male participants. Per ClinicalTrials.gov, last updated 2022-08-03.

Sponsored by Bogomolets National Medical University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
2,215
Sex
Male
01

Study summary

In 82.1% of patients with gunshot and mine-explosive injuries, the pain becomes chronic. The impact of the results of surgical treatment on the processes of chronic pain in this category of patients remains insufficiently studied. Therefore, the study of such a factor will be important to improve the results of pain treatment.

Read the detailed description

The influence of the results of surgical treatment in patients with gunshot and mine-explosive wounds on the formation of chronic pain needs to be studied, because the subjective feelings and emotional experiences experienced by patients during the wounding in combat conditions through the prism of psychological disorders have their own characteristics. Considering that in 82.1% of cases it is not possible to achieve a positive result of treatment, the data of our study will play an important role in the treatment of such patients.

02

Conditions studied

  • Chronic Pain

Browse trials for

Keywords

  • chronic pain, surgical treatment, wounds
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 2,215 is above the median of 126 across 688 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Bogomolets National Medical University is the lead sponsor of 37 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

all patients were injured during hostilities

Inclusion criteria

  • the presence of gunshot and mine-explosive injuries

Exclusion criteria

Exclusion Criteria:

  • absence of gunshot and mine-explosive injuries
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
2,215 participants (actual)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • retrospective analysis

    A retrospective analysis of disease histories for the period from 2014 to 2021 was carried out. Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.

    Other: visual analog scale

  • prospective study

    Recruitment of patients for the prospective study was carried out in the period from 02.24.2022 to 05.24.2022

    Other: visual analog scale

Interventions

  • Othervisual analog scale

    Data collection was carried out at all stages of treatment: medical and nursing brigade, military mobile hospital, military medical clinical center, during rehabilitation, within 12 months of the injury.

    Also known as: neuropathic pain Didier Bouhassiraa, Nadine Attala et al. Pain, 2005, 114: 29-36 (DN4)., Chaban Quality of Life Scale, The Hospital Anxiety and Depression Scale (HADS), Mississippi PTSD scale (military version)

06

What researchers measure

Primary outcomes

  1. visual analog scale

    from 0 to 10 points

    Time frame: 12 months

  2. Didier Bouhassiraa DN4

    4 or more points (a neuropathic pain component is present)

    Time frame: 12 months

  3. The Hospital Anxiety and Depression Scale

    0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity

    Time frame: 12 months

  4. Chaban Quality of Life Scale

    up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high

    Time frame: 12 months

  5. Mississippi PTSD scale (military version)

    the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD

    Time frame: 12 months

07

Study locations

1 site
  • Bogomolets National Medical University, Ministry of Health of Ukraine
    Kyiv, Ukraine
08

References and documents

Individual participant data

Plan to share: Undecided — I plan to share

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05485311
Lead sponsor
Bogomolets National Medical University
Responsible party
Vasyl' Horoshko (Chief researcher, Bogomolets National Medical University) — Principal investigator
First posted
Aug 3, 2022
Start date
Feb 24, 2022
Primary completion
May 24, 2022
Completion
Jul 24, 2022
Last update
Aug 3, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion